This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Joseph Timpona, PhD
Senior Scientist at Orbital Therapeutics
Speaker

Profile

Joseph Timpona leads the novel viral technologies group at Orbital Therapeutics. He has spent much of the last 12 years engineering viral vectors for therapeutics and vaccines in both academic and industry settings. He is a co-author on a patent for a viral-vectored Zika virus vaccine and patents for Anellovirus-based vectors. His areas of expertise include genome engineering and receptor targeting.

Agenda Sessions

  • Receptor-specific Targeting through Engineered VLPs

    5:15pm